期刊
NEUROLOGY INTERNATIONAL
卷 13, 期 2, 页码 143-150出版社
MDPI
DOI: 10.3390/neurolint13020014
关键词
SCN8A; SCN8A encephalopathy; oxcarbazepine
资金
- Tungs' Metroharbor Hospital [TTMHH-R1100003, TTMHH-R1100004]
Epileptic encephalopathy is a disease caused by extreme forms of intractable childhood epilepsy, which can result in severe delays in cognitive, sensory, and motor function development and be life-threatening in some cases. Genetic sequencing should be considered to identify the underlying genetic causes of the disease.
Epileptic encephalopathy is a condition resulting from extreme forms of intractable childhood epilepsy. The disease can cause severe delays in cognitive, sensory, and motor function development, in addition to being fatal in some cases. Missense mutations of SCN8A, which encodes Nav1.6, one of the main voltage-gated sodium channel subunits in neurons and muscles, have been linked to early infantile SCN8A encephalopathy. Herein, we report the case of a 5-month-old girl with SCN8A encephalopathy with a novel missense mutation. Apart from intractable seizures and autistic phenotypes, the results of blood and biochemical tests, electroencephalogram (EEG) results, and brain magnetic resonance imaging (MRI) results were all normal. As the phenotypes caused by these mutations cannot be identified by any clinical, neuroimaging, or electrophysiological features, genetic sequencing should be considered to identify the underlying genetic causes. Although phenytoin is recommended as a last-resort treatment for SCN8A encephalopathy, the administration of the oxcarbazepine, instead of phenytoin, mitigated this patient's intractable seizures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据